Skip to main content
Premium Trial:

Request an Annual Quote

PhenoTips Raises C$2.5M in Seed Funding

NEW YORK — Canadian medical genetics software firm PhenoTips said on Tuesday that it has raised C$2.5 million ($2.0 million) in an oversubscribed seed funding round.

The financing was led by GreenSky Accelerator Fund IV and included participation from Toronto Innovation Acceleration Partners, Thin Air Labs, Yorkville Partners, and angel investors from the GreenSky President's Club.

Established as a joint research venture between the Hospital for Sick Children and the University of Toronto, PhenoTips has developed a system for managing clinical phenotype, genetic, disease, and family history data for patients with genetic diseases. The company also offers a related product for cancer risk assessment.

PhenoTips said it will use the new funding to double its staff to 24 and expand its cloud-based product offerings.

"PhenoTips started eight years ago as an academic research project to help specialists record more standardized patient data at a nearby hospital’s genetics clinic," PhenoTips CEO Orion Buske said in a statement. "Today, we help specialists around the world not just record, but also use this information to help diagnose patients and advance genetics research."

The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.